Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Type 1 Diabetes Clinical Trials

104 recruiting trials for Type 1 Diabetes. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
104
Total Trials
104
Recruiting Now
3
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT07348432

The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes

Type 1 diabetes is an autoimmune health condition that requires daily injections of insulin. Insulin allows the body to use energy from carbohydrates in food. Disordered eating...

Sponsor: McGill UniversityEnrolling: 1061 location
RECRUITINGNCT04096794

Chinese Alliance for Type 1 Diabetes Multi-center Collaborative Research

The China Alliance for Type 1 Diabetes (CAT1D) is committed to exploring and implementing the model of graded diagnosis and treatment of type 1 diabetes and comprehensive...

Sponsor: Second Xiangya Hospital of Central South UniversityEnrolling: 5001 location
RECRUITINGNCT06081231

Open-Source Artificial Pancreas System Use Among People With Type 1 Diabetes Mellitus in China

This real-world observational study aims to reveal the current status of the open-source artificial pancreas system (APS) use among people with T1DM in China and assess the...

Sponsor: Third Affiliated Hospital, Sun Yat-Sen UniversityEnrolling: 5001 location
RECRUITINGPhase 2NCT07410975

Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage...

This study aims to evaluate the major pathologic response (MPR) rate of neoadjuvant therapy with sintilimab (PD-1 inhibitor) + IBI310 (anti-CTLA-4 antibody) + chemotherapy, and to...

Sponsor: Shanghai Pulmonary Hospital, Shanghai, ChinaEnrolling: 541 location
RECRUITINGNCT07409701

Gamification Intervertion in Children With Type 1 Diabetes

Objective: This study aims to examine the effect of education provided through gamification methods on health literacy and quality of life in children diagnosed with type 1...

Sponsor: KTO Karatay UniversityEnrolling: 521 location
RECRUITINGEarly Phase 1NCT06609356

Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes

This study aims to understand the heart and blood sugar health benefits of using an adjunctive therapy to lower high insulin levels in people with type 1 diabetes. The...

Sponsor: Vanderbilt University Medical CenterEnrolling: 271 location
RECRUITINGNCT07309094

Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD

Chronic kidney disease (CKD) is the progressive damage to kidney function, associated with an increased risk of cardiovascular diseases, such as stroke or myocardial infarct,...

Sponsor: Cardenal Herrera UniversityEnrolling: 2501 location
RECRUITINGNCT07297342

A Prospective Randomnised Controlled Trial Comparing Overall Patient Compliance in a Bariatric Surgical Pathway Using...

The aim of this study is to assess the impact of a newly intensified digital platform following bariatric surgery. This will be measured using several questionnaires. The...

Sponsor: Sint Dimpna Ziekenhuis GeelEnrolling: 2001 location
RECRUITINGNCT05015283

Efficacy and Safety of One-anastomosis Versus Roux-en-Y Gastric Bypass for Type 2 Diabetes Remission

Diabetes mellitus (T2DM) is the most common complication of obesity patients. According to previous literature reports, weight loss and metabolic surgery are powerful means to...

Sponsor: Beijing Friendship HospitalEnrolling: 2481 location
RECRUITINGNCT07386340

Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash...

A prospective, multicenter evaluation of performance and safety of the Eversense Gemini System with flash glucose measurement feature. The purpose of this clinical investigation...

Sponsor: Senseonics, Inc.Enrolling: 801 location
RECRUITINGPhase 4NCT03878459

Dapagliflozin Plus Pioglitazone in T1DM

Purpose: To examine the effect of addition of combination therapy with dapagliflozin plus pioglitazone to insulin on glucose control and plasma ketone concentration in patients...

Sponsor: The University of Texas Health Science Center at San AntonioEnrolling: 1203 locations
RECRUITINGNCT05653518

Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes

This study will examine the potential cardiovascular effect(s) of artificial pancreas (AP) technology in patients with type 1 diabetes. AP technology is a system of devices that...

Sponsor: University of VirginiaEnrolling: 401 location
RECRUITINGNCT06158503

Glycemic Control and Osteohealth in Adults Living With Type 1 Diabetes

Bone damage is frequently observed in type 1 diabetes, and hyperglycemia is associated with an increased risk of fracture. This pilot study in 25 people living with type 1...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 252 locations
RECRUITINGNCT06405373

Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART

This study is designed to compare two behavioral approaches to reduce diabetes distress ("the expected burdens, concerns, fears, and threats that arise from the challenges of...

Sponsor: University of North Carolina, Chapel HillEnrolling: 2001 location
RECRUITINGNCT07116434

Discovery Diabetes

The goal of this clinical trial is to learn if the Discovery Program can help improve diabetes management in adolescents and young adults with type 1 diabetes (T1D). The main...

Sponsor: Vanderbilt University Medical CenterEnrolling: 1501 location
RECRUITINGPhase 4NCT03463564

Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients

The transition from the Pediatric clinic to the adult care is a challenging period for young adults with type 1 diabetes, due to the high risk of poor glycemic control. Achieving...

Sponsor: University of Campania Luigi VanvitelliEnrolling: 1501 location
RECRUITINGNCT03648918

Genetics Of Autoimmunity In Type I Diabetes

The purpose of this study is to gain more information about the step-by-step process that causes someone to develop type 1 diabetes. Scientists think that a person's own immune...

Sponsor: Medical College of WisconsinEnrolling: 40001 location
RECRUITINGPhase 4NCT05454891

Extended Bolus for Meals in a Closed-loop System

This study aims to evaluate whether the use of an extended bolus will improve glucose control with high-fat high protein meals using a closed-loop system. The new knowledge gained...

Sponsor: University of California, San FranciscoEnrolling: 301 location
RECRUITINGPhase 1 / Phase 2NCT05426005

Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer

KEYNOTE-177 is currently the only randomized controlled phase III clinical trial evaluating the efficacy and safety of pembrolizumab versus standard chemotherapy combined with...

Sponsor: Sun Yat-sen UniversityEnrolling: 281 location
RECRUITINGNCT07209930

Inter- and Intraindividual Variability of the Acute Glucose Response to Exercise in Healthy Adults and People Living...

The goal of this clinical trial is to investigate if blood glucose responses are similar between and within individuals in response to standardized exercise in adults with and...

Sponsor: University College DublinEnrolling: 241 location
RECRUITINGNCT07434154

Evaluation of Oxidative Stress: Comparison Between Type 1 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults

After obtaining informed consent, the investigators will recruit 75 patients with T1DM and 75 with LADA with an age ≥ 18 years and ≤ 75 years, of both sexes. All patients will be...

Sponsor: Fondazione IRCCS Policlinico San Matteo di PaviaEnrolling: 751 location
RECRUITINGNCT07048795

Impact of the Mylife CamAPS FX System With the DEXCOM G6 Sensor on T1D Patients in France

This is a non-interventional, longitudinal, prospective, multicenter, post market-registration and national study conducted in France. The study is conducted among participants...

Sponsor: mylife Diabetes Care AGEnrolling: 12520 locations
RECRUITINGPhase 2 / Phase 3NCT06387199

Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous...

A closed-loop insulin system, often labelled the "artificial pancreas" (AP), consists of an insulin pump, a continuous glucose monitor, and an interface coordinating between them...

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health CentreEnrolling: 261 location
RECRUITINGNCT06503809

Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes

Despite strong evidence that tight control of blood sugar reduces the risk of diabetes complications, most people with type 1 diabetes do not achieve recommended blood sugar...

Sponsor: Washington University School of MedicineEnrolling: 581 location
RECRUITINGNCT05258292

Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes

In clinical practice, women living with type 1 diabetes frequently report that insulin requirements change across the menstrual cycle. Consequently, glycemic fluctuations are...

Sponsor: Institut de Recherches Cliniques de MontrealEnrolling: 861 location
RECRUITINGNCT06936280

Type 1 Diabetes and Diabetes Distress

The goal of this clinical trial is to reduce diabetes distress in emerging adults (18-35 years) with type 1 diabetes and moderate-to-severe diabetes distress. The expectation is...

Sponsor: Odense University HospitalEnrolling: 1003 locations
RECRUITINGPhase 1 / Phase 2NCT05565248

An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects...

This is an open-label, multicenter, Phase 1/2 study evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects with T1D

Sponsor: CRISPR Therapeutics AGEnrolling: 402 locations
RECRUITINGNCT02169518

Paraoxonase and HDL Qualities in Glycaemia and Inflammation

The incidence of coronary heart disease (CHD) is significant in the super-obese and diabetics. Inflammation is believed to play an important part in the development of CHD, and...

Sponsor: Manchester University NHS Foundation TrustEnrolling: 6001 location
RECRUITINGNCT06899191

Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED

The goal of this clinical trial is to improve the processes of Type 2 Diabetes (T2D) care coordination and treatment in the emergency department (ED) by utilizing clinical...

Sponsor: Rutgers, The State University of New JerseyEnrolling: 2001 location
RECRUITINGEarly Phase 1NCT05317455

Regulation of Brain Glucose Metabolism in Type 1 Diabetes

This is a prospective randomized placebo-controlled double-blind crossover pilot study determining the effect of dichloroacetate on brain function under clamped hypoglycemia in...

Sponsor: Yale UniversityEnrolling: 161 location
RECRUITINGPhase 2NCT07041268

Immunotherapy of the Recent-onset Type 1 Diabetes in Adolescents With Repeated Courses of Rituximab

Type 1 diabetes (T1D) is caused by destruction of pancreatic islet beta-cells that produce insulin - the hormone required for glucose uptake by body tissues and organs. Since loss...

Sponsor: Pirogov Russian National Research Medical UniversityEnrolling: 1162 locations
RECRUITINGNCT05713448

Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes

A registry of individuals with type 1 diabetes that visited the Department of Endocrinology of the University Hospitals of Leuven is established. The objective of this registry is...

Sponsor: Universitaire Ziekenhuizen KU LeuvenEnrolling: 1000001 location
RECRUITINGNCT04428658

Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric...

This study will test the hypothesis that supplemental synchronous video visits and supplemental asynchronous remote monitoring can each significantly improve glycemic control for...

Sponsor: University of California, DavisEnrolling: 821 location
RECRUITINGNCT05277532

Effect of Circadian Rhythm and Physical Exercise in Overweight Type 1 Diabetes Patients

Cardiometabolic risk in patients with abdominal obesity and type 1 diabetes can be moderated by life style modifications. There is an intimate link between gene regulation and...

Sponsor: Karolinska InstitutetEnrolling: 501 location
RECRUITINGNCT06092476

Trial to Evaluate Efficacy+Safety of Revita DMR Treatment Paradigm 1 and Retreatment in Type 2 Diabetes Patients

The objective of this study is to evaluate feasibility, safety, and efficacy of endoscopic DMR Treatment Paradigm 1 (compared to sham) and to evaluate feasibility, safety, and...

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Enrolling: 181 location
RECRUITINGNCT07212790

REAL-Fam Feasibility Study for Youth Diabetes Management

The goal of this clinical trial is to learn if the REAL-Fam occupational therapy intervention is feasible to study in a larger-scale randomized controlled trial. It will also seek...

Sponsor: University of North Carolina, Chapel HillEnrolling: 161 location
RECRUITINGNCT05984979

The Daytime Circadian Rhythm in Exhaled Volatile Organic Compounds in People Living Without and Diabetes

Exhaled volatile organic compounds will be measured during daytime with the goal to identifying circadian variability. The study incudes three subgroups: people without diabetes,...

Sponsor: University of BernEnrolling: 601 location
RECRUITINGNCT06532461

A Trial of Three- and Seven-days Insulin Infusions Set

More and more children and adolescents are using diabetes devices attached to the skin. The attachment of infusions sets to the skin provoke allergenic or toxic eczema, the...

Sponsor: Steno Diabetes Center CopenhagenEnrolling: 801 location
RECRUITINGPhase 1 / Phase 2NCT02846571

Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye

The intervention in this trial is intraocular islet transplantation. A single dose of 1000 - 3000 Islet Equivalents (IEQ)/kg recipient body weight (BW) will be infused into the...

Sponsor: Midhat H. AbdulredaEnrolling: 22 locations
RECRUITINGPhase 2NCT06762314

Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes

Type 1 Diabetes (T1DM) is a disease characterised by immune mediated destruction of the insulin-producing pancreatic beta cells. Overtime, obvious insulin deficiency develops...

Sponsor: Mostafa BahaaEnrolling: 1051 location
RECRUITINGPhase 3NCT07076199

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily...

This study compares insulin icodec, an insulin taken once a week to insulin glargine, an insulin taken once a day. The study medicine will be investigated in participants with...

Sponsor: Novo Nordisk A/SEnrolling: 87720 locations
RECRUITINGPhase 1 / Phase 2NCT06575426

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes...

This study is First In Human study for Encapsulated Porcine Islet Cells for Xenotransplantation (OPF-310). The purpose of this study to assess the safety, tolerability, and...

Sponsor: Otsuka Pharmaceutical Factory, Inc.Enrolling: 131 location
RECRUITINGNCT07011147

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

The goal of this randomized controlled trial is to compare the efficacy and safety of the iLet Bionic Pancreas (BP) System in adults with insulin-treated diabetes (type 1 diabetes...

Sponsor: University of Colorado, DenverEnrolling: 2402 locations
RECRUITINGNCT06728059

Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm

A randomized crossover trial assessing glycemic control using Reinforcement Learning trained Bolus Priming System (BPS\_RL) added to the the Automated Insulin Delivery as Adaptive...

Sponsor: Sue BrownEnrolling: 161 location
RECRUITINGNCT06985862

Development of Artificial Intelligence Tools for the Detection of Stress Markers and Consideration of Stress States in...

Stress refers to all the reactions of an organism subjected to exogenous or endogenous stress. In the context of diabetes, stress plays a critical role. There are two forms of...

Sponsor: Centre d'Etudes et de Recherche pour l'Intensification du Traitement du DiabèteEnrolling: 355 locations
RECRUITINGNCT06481904

Registry for Stage 2 Type 1 Diabetes

Stage 2 Type 1 Diabates (T1D) is an early stage of T1D characterized by dysglycemia but not yet leading to clinical symptoms. Progression of the disease to Stage 3 (clinical T1D),...

Sponsor: SanofiEnrolling: 20020 locations
RECRUITINGNCT07145671

The COCCOS Study: a Transition Program for Young Persons With Chronic Conditions

A study is undertaken to examine the feasibility of the newly developed transition program in adolescents with type 1 diabetes, asthma and obesity in a multicentric setting....

Sponsor: Universiteit AntwerpenEnrolling: 1501 location
RECRUITINGNCT06390371

Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)

The goal of this clinical trial is to compare the Spotlight AQ survey platform to the standard of care (SOC) pre-clinic assessment in adolescents \& young adults (16-25 years old)...

Sponsor: Children's Mercy Hospital Kansas CityEnrolling: 601 location
RECRUITINGNCT06256614

Washed Microbiota Transplantation for Type 1 Diabetes Mellitus

This is a real-world study to explore the safety and the efficacy of washed microbiota transplantation (WMT) for patients with Type 1 Diabetes Mellitus (T1DM).

Sponsor: The Second Hospital of Nanjing Medical UniversityEnrolling: 501 location
RECRUITINGPhase 1NCT07349381

A Food-Effect Study of CX11 in Healthy Participants

This study is to evaluate the food effect (FE) on the PK of 200 mg CX11 in healthy participants

Sponsor: Vincentage Pharma Co., LtdEnrolling: 321 location

Showing 50 of 104 trials.Search all Type 1 Diabetes trials